Primary Site >> Biliary tract Cancer

Gene >> FASLG

Journal: Hepatology. 1999 Dec;30(6):1398-404.
Title: Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Author: Que, F G|Phan, V A|Phan, V H|Celli, A|Batts, K|LaRusso, N F|Gores, G J
PMID: 10573518
Journal: Hepatology. 2000 Oct;32(4 Pt 1):761-9.
Title: Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
Author: Shimonishi, T|Isse, K|Shibata, F|Aburatani, I|Tsuneyama, K|Sabit, H|Harada, K|Miyazaki, K|Nakanuma, Y
PMID: 11003620
Journal: World J Gastroenterol. 2001 Dec;7(6):860-3.
Title: Fas counterattack in cholangiocarcinoma: a mechanism for immune evasion in human hilar cholangiocarcinomas.
Author: Li, Z Y|Zou, S Q
PMID: 11854917
Journal: Zhonghua Yi Xue Za Zhi. 2002 May 10;82(9):606-9.
Title: [The "Fas counterattack": a mechanism for immune evasion in human hilar cholangiocarcinomas].
Author: Li, Ziyu|Zhang, Lin|Zou, Shengquan
PMID: 12133481
Journal: Zhonghua Yu Fang Yi Xue Za Zhi. 2002 Dec;36(7):495-8.
Title: Regulative effect of IFN-gamma on the Fas/Fas L system of cholangiocarcinoma cells.
Author: Li, Ziyu|Wang, Jianming|Tang, Cong|Wang, Xin|Zou, Shengquan
PMID: 12411152
Journal: J Hepatobiliary Pancreat Surg. 2003;10(4):265-81.
Title: Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
Author: Nakanuma, Yasuni|Harada, Kenichi|Ishikawa, Akira|Zen, Yoh|Sasaki, Motoko
PMID: 14598145
Journal: Oncol Rep. 2004 Jun;11(6):1183-6.
Title: Fas and Fas ligand: Expression and soluble circulating levels in bile duct carcinoma.
Author: Murakami, Masateru|Sasaki, Tamito|Miyata, Hideki|Yamasaki, Souichirou|Kuwahara, Kenichi|Chayama, Kazuaki
PMID: 15138553
Journal: World J Gastroenterol. 2005 Jun 28;11(24):3719-23.
Title: Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma.
Author: Xu, Li-Ning|Zou, Sheng-Quan|Wang, Jian-Ming
PMID: 15968727
Journal: Cancer Res. 2005 Jul 15;65(14):6312-20.
Title: Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
Author: Kim, Jong-Hyun|Liu, Lan|Lee, Seung-Ok|Kim, Yong-Tae|You, Kyung-Ran|Kim, Dae-Ghon
PMID: 16024633
Journal: Int J Oncol. 2007 Oct;31(4):843-50.
Title: Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.
Author: Pan, George|Ahn, Eun-Young|Chen, Yabing|Feng, Gong|Reddy, Vishnu|Jhala, Nirag C|McDonald, Jay M
PMID: 17786316
Journal: Exp Mol Med. 2009 Feb 28;41(2):102-15.
Title: Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells.
Author: Yoo, Hee-Jung|Yun, Bo-Ra|Kwon, Jung-Hee|Ahn, Hyuk-Soo|Seol, Min-A|Lee, Mi-Jin|Yu, Goung-Ran|Yu, Hee-Chul|Hong, BeeHak|Choi, KwanYong|Kim, Dae-Ghon
PMID: 19287191
Journal: Dig Dis Sci. 2010 Oct;55(10):2844-52.
Title: The role of MAPK-ERK pathway in 67-kDa laminin receptor-induced FasL expression in human cholangiocarcinoma cells.
Author: Duan, Shi-Gang|Cheng, Long|Li, Da-Jiang|Zhu, Jin|Xiong, Yan|Li, Xiao-Wu|Wang, Shu-Guang
PMID: 20101459
Journal: PLoS One. 2010 Nov 17;5(11):e14037.
Title: Primary and malignant cholangiocytes undergo CD40 mediated Fas dependent apoptosis, but are insensitive to direct activation with exogenous Fas ligand.
Author: Humphreys, Elizabeth H|Williams, Kevin T|Adams, David H|Afford, Simon C
PMID: 21103345
Journal: Zhonghua Wai Ke Za Zhi. 2011 Apr 1;49(4):324-9.
Title: [Expression of WW domain containing oxidoreductase gene in cholangiocarcinoma and its effect on the biological behavior of cancer cell line RBE].
Author: Huang, Qiang|Zhu, Kai|Liu, Chen-hai|Xie, Fang|Xu, Peng|Tang, Zhi-gang
PMID: 21612698
Journal: PLoS One. 2014 Feb 28;9(2):e90264.
Title: Death receptor (DR4) haplotypes are associated with increased susceptibility of gallbladder carcinoma in north Indian population.
Author: Rai, Rajani|Sharma, Kiran L|Sharma, Surbhi|Misra, Sanjeev|Kumar, Ashok|Mittal, Balraj
PMID: 24587306
Journal: Oncol Rep. 2014 Jun;31(6):2635-43.
Title: UHRF1 depletion suppresses growth of gallbladder cancer cells through induction of apoptosis and cell cycle arrest.
Author: Qin, Yiyu|Wang, Jiandong|Gong, Wei|Zhang, Mingdi|Tang, Zhaohui|Zhang, Jun|Quan, Zhiwei
PMID: 24756644
Journal: Int J Mol Sci. 2015 Nov 25;16(12):28038-49.
Title: A Multiple Interaction Analysis Reveals ADRB3 as a Potential Candidate for Gallbladder Cancer Predisposition via a Complex Interaction with Other Candidate Gene Variations.
Author: Rai, Rajani|Kim, Jong Joo|Misra, Sanjeev|Kumar, Ashok|Mittal, Balraj
PMID: 26602921
Journal: Sci Rep. 2017 Oct 31;7(1):14419.
Title: Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells.
Author: Carnevale, Gianluca|Carpino, Guido|Cardinale, Vincenzo|Pisciotta, Alessandra|Riccio, Massimo|Bertoni, Laura|Gibellini, Lara|De Biasi, Sara|Nevi, Lorenzo|Costantini, Daniele|Overi, Diletta|Cossarizza, Andrea|de Pol, Anto|Gaudio, Eugenio|Alvaro, Domenico
PMID: 29089545